Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birch pollen immunotherapy for oral allergy syndrome triggered by apple
2011-004078-26Phase 4Completed
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- Oct 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Pollen Food Allergy Syndrome (PFAS), birch pollen allergy, allergic rhinitis (AR) and 1 more comparing Allergovit Birch Pollen with Placebo (2 arms). Primary endpoint: Change in sensitivity to uncooked apple. Started Oct 2011; status: completed.
02
Drugs
birch pollen allergoid
03
Conditions
Pollen Food Allergy Syndrome (PFAS)birch pollen allergyallergic rhinitis (AR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2011-004078-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004078-26.